CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 46 filers reported holding CIDARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,800 | -31.4% | 20,000 | -17.5% | 0.00% | – |
| Q2 2023 | $27,404 | -79.4% | 24,251 | -76.8% | 0.00% | – |
| Q1 2023 | $132,716 | +137.0% | 104,501 | +135.0% | 0.00% | – |
| Q4 2021 | $56,000 | -52.5% | 44,472 | -15.6% | 0.00% | – |
| Q3 2021 | $118,000 | +29.7% | 52,700 | +17.1% | 0.00% | – |
| Q2 2021 | $91,000 | -50.5% | 45,000 | -30.6% | 0.00% | – |
| Q3 2020 | $184,000 | -46.2% | 64,800 | -30.1% | 0.00% | – |
| Q2 2020 | $342,000 | +100.0% | 92,700 | +34.1% | 0.00% | – |
| Q1 2020 | $171,000 | +338.5% | 69,137 | +587.5% | 0.00% | – |
| Q4 2019 | $39,000 | +56.0% | 10,057 | -21.2% | 0.00% | – |
| Q3 2019 | $25,000 | -74.5% | 12,768 | -42.7% | 0.00% | – |
| Q3 2018 | $98,000 | -21.6% | 22,300 | -28.8% | 0.00% | – |
| Q1 2018 | $125,000 | -64.3% | 31,300 | -32.8% | 0.00% | – |
| Q2 2017 | $350,000 | +66.7% | 46,610 | +130.6% | 0.00% | – |
| Q4 2016 | $210,000 | +101.9% | 20,213 | +101.1% | 0.00% | – |
| Q2 2016 | $104,000 | – | 10,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,627,670 | $1,533,591 | 1.88% |
| 5AM Venture Management, LLC | 1,134,511 | $1,068,936 | 0.31% |
| Nantahala Capital Management | 2,538,406 | $2,391,686 | 0.20% |
| BVF INC/IL | 6,861,127 | $6,464,554 | 0.17% |
| Monashee Investment Management LLC | 369,099 | $347,765 | 0.14% |
| West Family Investments, Inc. | 368,910 | $347,587 | 0.12% |
| JEPPSON WEALTH MANAGEMENT, LLC | 137,560 | $129,609 | 0.06% |
| XTX Topco Ltd | 202,758 | $191,039 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 136,974 | $129 | 0.01% |
| Callan Capital, LLC | 103,462 | $97,482 | 0.01% |